Balazs; Mercedesz
Patent Applications and Registrations
Patent applications and USPTO patent grants for Balazs; Mercedesz.The latest application filed is for "il-17a/f heterologous polypeptides and therapeutic uses thereof".
- Balazs; Mercedesz - Hayward CA
- Balazs; Mercedesz - Burlingame CA
- Balazs; Mercedesz - Thousand Oaks CA
- Balazs; Mercedesz - Seattle WA
- - Hayward CA US
| Patent | Date |
|---|---|
| Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20220204606 - Arnott; David P ; et al. | 2022-06-30 |
| Il-17a/f Heterologous Polypeptides And Therapeutic Uses Thereof App 20200377585 - ARNOTT; David P. ; et al. | 2020-12-03 |
| Anti-hemagglutinin Antibodies And Methods Of Use App 20190023770 - Xu; Min ; et al. | 2019-01-24 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20180305465 - Stevens; Jennitte Leann ; et al. | 2018-10-25 |
| Anti-hemagglutinin antibodies and methods of use Grant 9,908,931 - Xu , et al. March 6, 2 | 2018-03-06 |
| Anti-influenza B Virus Hemagglutinin Antibodies And Methods Of Use App 20170320937 - Swem; Lee ; et al. | 2017-11-09 |
| Anti-influenza B virus hemagglutinin antibodies and methods of use Grant 9,745,365 - Swem , et al. August 29, 2 | 2017-08-29 |
| Anti-hemagglutinin antibodies and methods of use Grant 9,598,481 - Xu , et al. March 21, 2 | 2017-03-21 |
| Anti-hemagglutinin Antibodies And Methods Of Use App 20160168230 - XU; Min ; et al. | 2016-06-16 |
| Anti-hemagglutinin antibodies and methods of use Grant 9,284,365 - Xu , et al. March 15, 2 | 2016-03-15 |
| Anti-influenza B Virus Hemagglutinin Antibodies And Methods Of Use App 20150274812 - Swem; Lee ; et al. | 2015-10-01 |
| Anti-hemagglutinin Antibodies And Methods Of Use App 20150259400 - Xu; Min ; et al. | 2015-09-17 |
| Anti-hemagglutinin antibodies and methods of use Grant 9,067,979 - Xu , et al. June 30, 2 | 2015-06-30 |
| Anti-hemagglutinin Antibodies And Methods Of Use App 20140248286 - Xu; Min ; et al. | 2014-09-04 |
| Anti-hemagglutinin Antibodies And Methods Of Use App 20140161822 - XU; Min ; et al. | 2014-06-12 |
| Enrichment Of Antigen-specific Plasmablasts App 20140134638 - ZHANG; Juan ; et al. | 2014-05-15 |
| Apoptotic Anti-ige Antibodies App 20140115729 - Wu; Lawren ; et al. | 2014-04-24 |
| Apoptotic anti-IgE antibodies Grant 8,632,775 - Wu , et al. January 21, 2 | 2014-01-21 |
| Nucleic acid encoding apoptotic anti-IgE antibodies Grant 08618274 - | 2013-12-31 |
| Nucleic acid encoding apoptotic anti-IgE antibodies Grant 8,618,274 - Wu , et al. December 31, 2 | 2013-12-31 |
| Methods of using apoptotic anti-IGE antibodies Grant 8,586,040 - Wu , et al. November 19, 2 | 2013-11-19 |
| Methods Of Using Apoptotic Anti-ige Antibodies App 20120177635 - WU; LAWREN ; et al. | 2012-07-12 |
| Nucleic acid encoding apoptotic anti-ige antibodies App 20120178127 - Wu; Lawren ; et al. | 2012-07-12 |
| Apoptotic Anti-ige Antibodies App 20120149881 - Wu; Lawren ; et al. | 2012-06-14 |
| Transgenic Animals Expressing Human Ige-m1' App 20120144512 - Wu; Lawren ; et al. | 2012-06-07 |
| Apoptotic anti-IgE antibodies Grant 8,071,097 - Wu , et al. December 6, 2 | 2011-12-06 |
| Polypeptides That Bind Br3 And Uses Thereof App 20100280227 - AMBROSE; CHRISTINE M. ; et al. | 2010-11-04 |
| Apoptotic Anti-IgE Antibodies App 20090010924 - Wu; Lawren ; et al. | 2009-01-08 |
| Polypeptides That Bind Br3 and Uses Thereof App 20080181888 - Ambrose; Christine M. ; et al. | 2008-07-31 |
| IL-17A/F heterologous polypeptides and therapeutic uses thereof App 20070160576 - Arnott; David P. ; et al. | 2007-07-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 